Stephanie Koh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephanie Koh has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Umair Khalid
Michael E. DeBakey VA Medical Center, Houston, Texas; Section of Cardiology, Baylor College of Medicine, Houston, TX, United States
2 shared publications - Xiaoming Jia
Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, USA
2 shared publications - Ali E. Denktas
Baylor College of Medicine, Houston, TX
1 shared publication Anupama B. K.
Section of Cardiology, Department of Medicine Baylor College of Medicine Houston Texas USA
1 shared publication- Feng Gao
Department of Internal Medicine Baylor College of Medicine Houston Texas USA
1 shared publication Graham Rector
Department of Internal Medicine, Baylor College of Medicine, Houston, Texas
1 shared publication
Latest Publications
- 28 May 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (2) , 926-933
Optimal Stenting Technique for Lesions at the Ostium of the Left Anterior Descending Artery: A Systematic Review and Meta‐Analysis
Background: Ostial lesions of the left anterior descending (LAD) artery present unique challenges for interventional cardiologists. The two principal techniques for percutaneous coronary intervention (PCI) of ostial LAD lesions are ostial stenting (OS) and cross‐over stenting (CS). Current data comparing the efficacy of these techniques have been mixed. Aims: Determine whether there are differences in efficacy between CS and OS for PCI of ostial LAD lesions. Methods: We performed a systematic review of studies comparing CS and OS techniques regarding long‐term outcomes (≥ 1 year). Using the Mantel‐Haenszel random effects model, we computed relative risk (RR) with 95% confidence intervals (CI) for major adverse cardiovascular events (MACE), death, myocardial infarction (MI), target lesion revascularization (TLR), and stent thrombosis (ST) between CS and OS groups. For significant outcomes, a subgroup analysis was performed, dividing studies by percent intravascular ultrasound (IVUS) use (> 50% vs. 50%). Results: Eight cohort studies with a total of 1448 participants were included in the meta‐analysis. CS was favored with respect to TLR (5.5% vs. 10.6%; RR 0.57, 95% CI 0.34−0.95, p = 0.03) and ST (0.9% vs. 4.3%; RR 0.34, 95% CI 0.13−0.93, p = 0.04). There was no significant association between stenting technique with MACE, death or MI, though significant heterogeneity was observed in analyses of these outcomes. In subgroup analysis, significant association favoring CS in TLR and ST was observed in the lower IVUS use but not in the higher IVUS use subgroup. Conclusion: Our meta‐analysis suggests that CS is associated with lower long‐term risk for TLR and ST compared to OS in PCI of ostial LAD lesions, especially if intravascular imaging is not available.
- 28 May 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (2) , 926-933
Optimal Stenting Technique for Lesions at the Ostium of the Left Anterior Descending Artery: A Systematic Review and Meta‐Analysis
Background: Ostial lesions of the left anterior descending (LAD) artery present unique challenges for interventional cardiologists. The two principal techniques for percutaneous coronary intervention (PCI) of ostial LAD lesions are ostial stenting (OS) and cross‐over stenting (CS). Current data comparing the efficacy of these techniques have been mixed. Aims: Determine whether there are differences in efficacy between CS and OS for PCI of ostial LAD lesions. Methods: We performed a systematic review of studies comparing CS and OS techniques regarding long‐term outcomes (≥ 1 year). Using the Mantel‐Haenszel random effects model, we computed relative risk (RR) with 95% confidence intervals (CI) for major adverse cardiovascular events (MACE), death, myocardial infarction (MI), target lesion revascularization (TLR), and stent thrombosis (ST) between CS and OS groups. For significant outcomes, a subgroup analysis was performed, dividing studies by percent intravascular ultrasound (IVUS) use (> 50% vs. 50%). Results: Eight cohort studies with a total of 1448 participants were included in the meta‐analysis. CS was favored with respect to TLR (5.5% vs. 10.6%; RR 0.57, 95% CI 0.34−0.95, p = 0.03) and ST (0.9% vs. 4.3%; RR 0.34, 95% CI 0.13−0.93, p = 0.04). There was no significant association between stenting technique with MACE, death or MI, though significant heterogeneity was observed in analyses of these outcomes. In subgroup analysis, significant association favoring CS in TLR and ST was observed in the lower IVUS use but not in the higher IVUS use subgroup. Conclusion: Our meta‐analysis suggests that CS is associated with lower long‐term risk for TLR and ST compared to OS in PCI of ostial LAD lesions, especially if intravascular imaging is not available.
- Open Access
- 1 November 2022
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 49 (6)
A Case of Isolated Cardiac Burkitt Lymphoma Causing Right-Sided Heart Failure
Primary cardiac tumors are rare, as the most common cause of cardiac masses is from metastatic disease. In this article, a unique case of isolated cardiac Burkitt lymphoma causing right-sided heart failure in a 70-year-old man who presented to the emergency department with abdominal distension and lower-extremity swelling is described. The right ventricular mass was initially identified via computed tomographic scans of the abdomen and pelvis. Further workup included transthoracic echocardiogram and cardiac magnetic resonance imaging that showed extension of the mass into the right atrium and pericardium. Staging imaging and bone marrow biopsy revealed no evidence of metastatic disease. Cytology of the peritoneal fluid and biopsy of the right ventricular mass confirmed Burkitt lymphoma. The cardiac mass substantially decreased in size and the right-sided heart failure resolved after the initiation of chemotherapy, which highlights the importance of prompt diagnosis and treatment of Burkitt lymphoma.
- 1 November 2022
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 49 (6)
Open AccessA Case of Isolated Cardiac Burkitt Lymphoma Causing Right-Sided Heart Failure
Primary cardiac tumors are rare, as the most common cause of cardiac masses is from metastatic disease. In this article, a unique case of isolated cardiac Burkitt lymphoma causing right-sided heart failure in a 70-year-old man who presented to the emergency department with abdominal distension and lower-extremity swelling is described. The right ventricular mass was initially identified via computed tomographic scans of the abdomen and pelvis. Further workup included transthoracic echocardiogram and cardiac magnetic resonance imaging that showed extension of the mass into the right atrium and pericardium. Staging imaging and bone marrow biopsy revealed no evidence of metastatic disease. Cytology of the peritoneal fluid and biopsy of the right ventricular mass confirmed Burkitt lymphoma. The cardiac mass substantially decreased in size and the right-sided heart failure resolved after the initiation of chemotherapy, which highlights the importance of prompt diagnosis and treatment of Burkitt lymphoma.
- Open Access
- 11 July 2022
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 18 (1) , 48-53
A Right Atrial Mass with Fever and Cutaneous Nodules
Primary cardiac tumors, although exceedingly rare, should be considered in the differential diagnosis during workup of any cardiac mass. Extranodal cardiac lymphomas have a natural aggressive course due to delayed diagnosis. We present a 71-year-old male with a dual-chamber pacemaker who presented with fevers and new cutaneous nodules. He was found to have a right atrial primary anaplastic large-cell lymphoma and had a complete metabolic response after chemotherapy. Our case highlights the importance of a multimodality approach in the diagnosis of cardiac tumors and during follow-up after treatment.
- 11 July 2022
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 18 (1) , 48-53
Open AccessA Right Atrial Mass with Fever and Cutaneous Nodules
Primary cardiac tumors, although exceedingly rare, should be considered in the differential diagnosis during workup of any cardiac mass. Extranodal cardiac lymphomas have a natural aggressive course due to delayed diagnosis. We present a 71-year-old male with a dual-chamber pacemaker who presented with fevers and new cutaneous nodules. He was found to have a right atrial primary anaplastic large-cell lymphoma and had a complete metabolic response after chemotherapy. Our case highlights the importance of a multimodality approach in the diagnosis of cardiac tumors and during follow-up after treatment.
- 20 November 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (4) , 448-452
A Left Atrial Mass in the Time of COVID
- 20 November 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (4) , 448-452
A Left Atrial Mass in the Time of COVID
- Open Access
- 23 April 2013
- Published by Medknow in Singapore Medical Journal
- Vol. 54 (4) , e79-e82
Multidetector computed tomography diagnosis of splenic flexure volvulus: usefulness of multiplanar reformats
Formed in 1959, the Singapore Medical Association (SMA) is the national medical organisation representing the majority of medical practitioners in both the public and private sectors
- 23 April 2013
- Published by Medknow in Singapore Medical Journal
- Vol. 54 (4) , e79-e82
Open AccessMultidetector computed tomography diagnosis of splenic flexure volvulus: usefulness of multiplanar reformats
Formed in 1959, the Singapore Medical Association (SMA) is the national medical organisation representing the majority of medical practitioners in both the public and private sectors